Perioperative Hypoxemia in Pediatrics

NCT ID: NCT04723017

Last Updated: 2021-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

17000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-21

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim was to develop and validation of perioperative hypoxemia using clinical big data and deep learning technique in pediatric patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoxemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Retrospective analysis cohort

We analyze pre-existing data base and develop machine-learning-based system that predicts the risk of hypoxemia

Intervention Type OTHER

Prospective validation cohort

We validate our model to predict the risk of hypoxemia to prospective cohort

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric patients undergoing general or spinal anesthesia and monitored anesthesia care

Exclusion Criteria

* none
Maximum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hee-Soo Kim

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hee-Soo Kim

Seoul, Soul-t'ukpyolsi, South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hee-Soo Kim, professor

Role: CONTACT

+82-2-2072-3664

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hee-Soo Kim, MD.PhD

Role: primary

08201052878006

Eun-Hee Kim, MD.

Role: backup

08201099335014

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-208-1179

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.